Results 101 to 110 of about 231,116 (154)

Metastatic melanoma with heterologous bone after neoadjuvant immunotherapy: diagnostic insights. [PDF]

Pathologica
Pepe L, Fiorentino V, Ieni A, Santarpia M, Fazio A, Vaccaro M, Borgia F, Ferrara G, Lentini M.   +8 more
europepmc   +1 more source

Biomarkers of neoadjuvant immunotherapy for locally advanced head and neck cancer: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
He J, Ma Y, Yu G, Wang W, Shi X, Chen S, Zheng H, Zhu M, Zhang C.   +8 more
europepmc   +1 more source

Organ preservation after neoadjuvant immunotherapy in mismatch repair-deficient colorectal cancer: response assessment, watch-and-wait, and salvage surgery. [PDF]

Front Oncol
Yao N, Xu G, Duan N, Han F, Li W, Qu J.
europepmc   +1 more source

Impact of mucinous histology on the efficacy of neoadjuvant immunotherapy in localized mismatch repair-deficient colorectal cancer. [PDF]

BMC Cancer
Hong Z, Chen S, Zhang C, Yu J, Liao L, Zheng M, Han K, Hou Z, Wu X, Jiang W, Ding PR.   +10 more
europepmc   +1 more source

A subset of MMR-proficient colon cancers responds to neoadjuvant immunotherapy. [PDF]

Mol Oncol
Piumatti E, Germano G, Vitiello PP, Bardelli A.   +3 more
europepmc   +1 more source

Personalization of Neoadjuvant Immunotherapy in High-Risk Resectable Melanoma and Utility of ctDNA as a Biomarker of Immunotherapy Response. [PDF]

Ann Surg Oncol
Lawless A, Effiom DN, Burbano A, Sharova T, Otten TJ, Basnet M, Spurr E, Shankar T, Crespo MC, Czapla JA, Bangrazi G, Emerick K, Sullivan RJ, Boland GM, Mooradian MJ, Cohen S.   +15 more
europepmc   +1 more source

Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection. [PDF]

Ann Surg Oncol
Herb J, Bassett RL, Torres-Cabala CA, Prieto VG, Patel SP, Holder AM, Fisher SB, Lucci A, Wargo J, Amaria RN, Davies MA, Glitza Oliva IC, Tawbi HA, McQuade J, Ikeguchi AP, Wong MK, Diab AK, Gershenwald JE, Ross MI, Weiser R.   +19 more
europepmc   +1 more source

Neoadjuvant immunotherapy followed by surgery versus non-operative management in dMMR/MSI gastroesophageal adenocarcinomas: a case series and review of the literature. [PDF]

ESMO Gastrointest Oncol
Demigné JB, Caillol F, Guiramand J, Heinisch M, Mitry E, Chanez B, Benizri F, Collineau B, Mari R, Dano D, Saadoun JE, de la Fouchardière C.   +11 more
europepmc   +1 more source

Clinicopathological and molecular characteristics associated with pathological complete response in neoadjuvant immunotherapy for breast cancer. [PDF]

Front Immunol
Zhang B, Chen Z, Mao R, Zhu J, Cai W, Zhao B.   +5 more
europepmc   +1 more source

Neutrophil Extracellular Traps Predict Prognosis and Neoadjuvant Immunotherapy Response in Gastric Cancer. [PDF]

J Inflamm Res
Zhong W, Wang Q, Sun L, Zhu H, Cai H, Dong J, Chen G, Liu A, Du J.   +8 more
europepmc   +1 more source